Etoricoxib prices in the US dropped sharply in May xxxx due to lower import costs and an oversupplied domestic market. One of the main reasons for the price fall was the availability of cheap imports from China where suppliers were dealing with inventory piles and production surpluses. To clear out the excess inventory, Chinese suppliers were offering Etoricoxib at very low prices and US buyers took advantage of it and imported at lower landed costs.
-
Etoricoxib prices in the US dropped in May xxxx due to lower import costs and Chinese exporters offering deep discounts.
-
High domestic inventory meant there was no immediate need to buy Etoricoxib, so buyers were focused on clearing stock rather than new orders.
-
The temporary China-US tariff reduction lifted the market sentiment but didn’t lead to immediate Etoricoxib demand increase.
-
Supply chain issues and delivery delays in the US also impacted pharma production, reducing...
